GSK vs. GAW.L
GSK (GlaxoSmithKline plc) and GAW.L (Games Workshop Group plc) are both stocks. GSK operates in Drug Manufacturers - General (Healthcare), while GAW.L operates in Leisure (Consumer Cyclical). Over the past 10 years, GSK returned 4.64%/yr vs 49.39%/yr for GAW.L. At a 0.18 correlation, their price movements are largely independent.
Performance
GSK vs. GAW.L - Performance Comparison
Loading charts...
Different Trading Currencies
GSK is traded in USD, while GAW.L is traded in GBp. To make them comparable, the GAW.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GSK achieves a 4.91% return, which is significantly higher than GAW.L's -0.29% return. Over the past 10 years, GSK has underperformed GAW.L with an annualized return of 4.64%, while GAW.L has yielded a comparatively higher 49.39% annualized return.
GSK
- 1D
- -1.71%
- 1M
- 1.25%
- YTD
- 4.91%
- 6M
- 6.15%
- 1Y
- 27.36%
- 3Y*
- 17.87%
- 5Y*
- 4.68%
- 10Y*
- 4.64%
GAW.L
- 1D
- -0.53%
- 1M
- -5.80%
- YTD
- -0.29%
- 6M
- -2.43%
- 1Y
- 18.68%
- 3Y*
- 33.82%
- 5Y*
- 13.14%
- 10Y*
- 49.39%
GSK vs. GAW.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.91% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
GAW.L Games Workshop Group plc | -0.29% | 59.71% | 37.99% | 26.79% | -20.05% | -10.12% | 93.05% | 116.73% | 14.00% | 350.72% |
Correlation
The correlation between GSK and GAW.L is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2007 | 0.18 |
Fundamentals
GSK:
$103.15B
GAW.L:
£6.24B
GSK:
$2.85
GAW.L:
£11.54
GSK:
17.78
GAW.L:
16.35
GSK:
1.19
GAW.L:
1.28
GSK:
3.16
GAW.L:
5.08
GSK:
4.38
GAW.L:
19.53
GSK:
$32.78B
GAW.L:
£1.23B
GSK:
$23.87B
GAW.L:
£881.50M
GSK:
$11.30B
GAW.L:
£574.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSK vs. GAW.L — Risk / Return Rank
GSK
GAW.L
GSK vs. GAW.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and Games Workshop Group plc (GAW.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GSK | GAW.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.34 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.16 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.48 | 1.24 | +0.24 |
| Martin ratioReturn relative to average drawdown | 3.38 | 2.37 | +1.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GSK | GAW.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 0.68 | +0.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.40 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 1.33 | -1.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.65 | -0.33 |
Drawdowns
GSK vs. GAW.L - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.70%, smaller than the maximum GAW.L drawdown of -67.53%. Use the drawdown chart below to compare losses from any high point for GSK and GAW.L.
Loading charts...
Drawdown Indicators
| GSK | GAW.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.70% | -67.53% | +11.83% |
Max Drawdown (1Y)Largest decline over 1 year | -18.63% | -15.05% | -3.58% |
Max Drawdown (3Y)Largest decline over 3 years | -28.46% | -22.45% | -6.01% |
Max Drawdown (5Y)Largest decline over 5 years | -50.10% | -60.90% | +10.80% |
Max Drawdown (10Y)Largest decline over 10 years | -50.10% | -61.40% | +11.30% |
Current DrawdownCurrent decline from peak | -15.91% | -9.32% | -6.59% |
Average DrawdownAverage peak-to-trough decline | -18.87% | -21.02% | +2.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.11% | 7.86% | +0.25% |
Volatility
GSK vs. GAW.L - Volatility Comparison
The current volatility for GlaxoSmithKline plc (GSK) is 6.42%, while Games Workshop Group plc (GAW.L) has a volatility of 9.42%. This indicates that GSK experiences smaller price fluctuations and is considered to be less risky than GAW.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GSK | GAW.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 9.42% | -3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 18.51% | 17.56% | +0.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.94% | 27.29% | -0.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.06% | 33.03% | -7.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.89% | 37.21% | -14.32% |
Dividends
GSK vs. GAW.L - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 3.41%, more than GAW.L's 2.57% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GAW.L Games Workshop Group plc | 2.57% | 3.49% | 3.08% | 4.51% | 3.50% | 1.96% | 1.65% | 2.62% | 4.28% | 5.32% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 3.41% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
Financials
GSK vs. GAW.L - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and Games Workshop Group plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GSK vs. GAW.L - Profitability Comparison
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a gross profit of 5.75B and revenue of 7.63B. Therefore, the gross margin over that period was 75.4%.
GAW.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Games Workshop Group plc reported a gross profit of 235.50M and revenue of 332.10M. Therefore, the gross margin over that period was 70.9%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported an operating income of 2.29B and revenue of 7.63B, resulting in an operating margin of 30.1%.
GAW.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Games Workshop Group plc reported an operating income of 141.80M and revenue of 332.10M, resulting in an operating margin of 42.7%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a net income of 1.74B and revenue of 7.63B, resulting in a net margin of 22.8%.
GAW.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Games Workshop Group plc reported a net income of 105.50M and revenue of 332.10M, resulting in a net margin of 31.8%.
Frequently Asked Questions
GSK and GAW.L have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GSK and GAW.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer